Get the Stockscreener App
42.20
2.06%
0.85
After Hours:
42.00
-0.20
-0.47%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $42.20, with a volume of 1.08M.
It is up +2.06% in the last 24 hours and down -8.64% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
See More
Previous Close:
$41.35
Open:
$40.99
24h Volume:
1.08M
Relative Volume:
0.92
Market Cap:
$2.24B
Revenue:
$238.11M
Net Income/Loss:
$-31.45M
P/E Ratio:
-66.62
EPS:
-0.6334
Net Cash Flow:
$7.66M
1W Performance:
+6.86%
1M Performance:
-8.64%
6M Performance:
+21.09%
1Y Performance:
+222.38%
1-Day Range:
$39.92
$42.78
1-Week Range:
$38.31
$46.15
52-Week Range:
$12.38
$46.95
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
42.20 | 2.19B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Wells Fargo | Overweight |
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Axogen earnings on deck as nerve repair reimbursement gains gather steam - Investing.com UK
AxoGen Inc (AXGN) Institutional Confidence - TradingKey
AxoGen Inc (AXGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AxoGen Inc (AXGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
234,495 Shares in AxoGen, Inc. $AXGN Acquired by SummitTX Capital L.P. - MarketBeat
First Light Asset Management LLC Has $132.61 Million Stock Holdings in AxoGen, Inc. $AXGN - MarketBeat
AxoGen Inc (AXGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AxoGen Inc (AXGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AxoGen Inc (AXGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AxoGen Inc (AXGN) Cash Flow - TradingKey
Wall Street Zen Upgrades AxoGen (NASDAQ:AXGN) to Buy - MarketBeat
TradingKey - TradingKey
AxoGen Inc (AXGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AXGN|AxoGen Inc|Price:41.130|Chg%:+1.640 - TradingKey
AXGN|AxoGen Inc|Price:39.490|Chg%:-0.240 - TradingKey
Axogen Inc. (AXGN) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock Edges LowerROIC Trend Report - dars.gov.et
AxoGen Inc (AXGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Earnings Preview: AxoGen to Report Financial Results Pre-market on July 29 - Moomoo
Does NZS Capital’s ‘Optionality’ Stake and Coverage Momentum Change The Bull Case For Axogen (AXGN)? - simplywall.st
Axogen Inc. (AXGN) Consolidates Near $39.40 as Volume Points to Potential BreakoutStock Buy Zone - dars.gov.et
AxoGen (AXGN) Projected to Release Quarterly Earnings on Wednesday - MarketBeat
NZS Capital Added Axogen (AXGN) as an Optionality Position - Yahoo Finance
WCM Investment Management LLC Acquires 158,914 Shares of AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Rating Lowered to Hold at Wall Street Zen - MarketBeat
(AXGN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 - Sahm
Axogen to report Q2 2026 financial results on J... - Pluang
Aubrey Capital Management Ltd Invests $2.88 Million in AxoGen, Inc. $AXGN - MarketBeat
Axogen Inc. (AXGN) Q1 2026 Earnings: Slight EPS Miss Highlights Cost PressuresQuarterly Profit Report - dars.gov.et
Axogen Insiders Sold US$6.2m Of Shares Suggesting Hesitancy - Moomoo
What Axogen (AXGN)'s Russell Index Removal Means For Shareholders - simplywall.st
Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50 - Moomoo
AXGN Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesNet Profit Margin - dars.gov.et
Axogen Inc. (AXGN) Q1 2026 Earnings: Narrow EPS Miss and Positive Stock Reaction Signal Cautious Optimism - dars.gov.et
Axogen stock hits 52-week high at 46.05 USD - Investing.com UK
Axogen stock hits 52-week high at 46.05 USD By Investing.com - Investing.com Nigeria
Will Axogen’s (AXGN) Russell Index Removal Reshape Its Liquidity Profile and Risk‑Reward Narrative? - Sahm
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Index - marketscreener.com
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell Microcap Index - marketscreener.com
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Price to earnings forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Daily Brief Health Care: AxoGen Inc, Dentsply International and more - Smartkarma
Axogen Inc. (AXGN) Edges Higher as Shares Test Key Resistance at $47.18Wyckoff Distribution - dars.gov.et
Form 4 Axogen Inc For: 26 June By Investing.com - Investing.com Nigeria
AXGN News | AXOGEN INC (NASDAQ:AXGN) - ChartMill
Axogen (AXGN) director receives 4,392 restricted stock units in annual equity grant - Stock Titan
Axogen (AXGN) director Alan Levine granted 4,392 RSUs valued at $185K - Stock Titan
Axogen (AXGN) director receives 4,392 RSUs in $185,000 equity grant - Stock Titan
Axogen (AXGN) director Wendell McBride awarded 4,392 RSUs valued at $185,000 - Stock Titan
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Axogen Inc Stock (AXGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Weiler Kathy Johnson | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
14,150 |
| Wendell Amy McBride | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
107,976 |
| THOMAS PAUL | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
18,867 |
0 |
32,395 |
| TYNDALL JOSEPH A. | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
14,150 |
| JOHNSON JOHN | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
14,150 |
| Burke William P. Mr. | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
14,250 |
| Wendell Amy McBride | Director |
May 08 '26 |
Option Exercise |
14.85 |
1,647 |
24,458 |
95,473 |
| Wendell Amy McBride | Director |
May 08 '26 |
Sale |
42.60 |
1,647 |
70,162 |
93,826 |
1.04%
11.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):